Diana V. Do, MD: 3-Year PHOTON Data on Aflibercept 8 mg for DME
At AAO 2024, Do describes the durable vision gains and anatomic improvements achieved with aflibercept 8 mg for DME over 3 years of the PHOTON trial.
Matthew Cunningham, MD: 1-Year ELEVATUM Data Target Disparities in DME
At AAO 2024, Cunningham describes the clinical response and safety of faricimab (Vabysmo) in underrepresented populations with diabetic macular edema.
The Future of Lipoprotein Apheresis, with Laurence Sperling, MD, and Eugenia Gianos, MD
In part 3 of our Special Report on lipoprotein apheresis, Sperling and Gianos discuss future considerations for use and the evolving landscape of lipid management.
Optimizing Use and Clinical Considerations for Lipoprotein Apheresis, with Laurence Sperling, MD, and Eugenia Gianos, MD
In part 2 of this 3-part series, Sperling and Gianos highlight the role of lipoprotein apheresis in contemporary settings and the supporting evidence base.
Exploring the Role, History of Lipoprotein Apheresis, with Laurence Sperling, MD, and Eugenia Gianos, MD
Laurence Sperling, MD, and Eugenia Gianos, MD, discuss the historical context and underutilization of lipoprotein apheresis in part 1 of a 3-part video series.
The Potential Role of Dupilumab in COPD Management, with Antonio Anzueto, MD
Antonio Anzueto, MD, discusses how dupilumab fits into treatment algorithms for patients with uncontrolled COPD.
Stephanie Christenson, MD: An "Exciting" New Era in COPD Management
Stephanie Christenson, MD, discusses the impact of recent regulatory approvals and pipeline movement for chronic obstructive pulmonary disease.
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
Calabrese discussed considerations for patients with rheumatic disease diagnosed with COVID-19 and the virus’s role in promoting inflammation.
Is Cardiology Overtreating Aortic Stenosis? with Linda Gillam, MD, MPH
Linda Gillam, MD, MPH, discusses the idea that the cardiology community may. be overtreating aortic stenosis.
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Xanomeline trospium chloride offers a new pathway in schizophrenia treatment, improving cognitive symptoms without D2 receptor-related side effects like tardive dyskinesia.
Considerations for Clinicians When Prescribing Muscarinic Modulators in Schizophrenia, with Chelsie Monroe
HCPLive spoke with Monroe regarding muscarinic modulators, both the ones in development and xanomeline trospium chloride capsules (Cobenfy).
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Mease discussed the importance of comparator studies in a growing treatment landscape for PsA.
HCPLive Five at Maui Derm NP+PA Fall 2024
Counting down the most impactful news at major medical meetings, it’s the HCPLive Five! This episode focuses on 5 key updates from Maui Derm NP+PA Fall 2024 in Nashville.
If Successful, Inclisiran Primary Prevention Trial Could Expand Patient Population by More than 22 Million
Rahul Aggarwal, MD, discusses how the VICTORION-1 PREVENT trial eligibility criteria apply to the general US population.
Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification
This segment of Marghoob’s interview featured a discussion of pigmented lesion identification and use of technology such as AI.
Steve Nissen, MD: Optimizing Lp(a) Management by Learning from Missteps with LDL-C
Steve Nissen, MD, discusses how the cardiology community needs to learn from previous mistakes in uptake of LDL-C lowering therapies as it approaches an age of Lp(a)-lowering agents.
Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD
In this interview, Marghoob highlights some of the biggest diagnostic challenges faced by dermatologists and other providers when it comes to pigmented lesions.
Christie Ballantyne, MD: 'Exciting' Time for FCS Pipeline
A comparison of the PALISADE and BALANCE trials, with commentary from a leading cardiologist, as the community nears a potential approval in FCS.
Considering Viral Infections in Patients With Rheumatic Disease, with Leonard Calabrese, DO
Calabrese discussed factors for rheumatologists to keep in mind, including recent travel and screening for viral infections.
Advances in Non-Statin Therapies for Dyslipidemia, with Christie Ballantyne, MD
Christie Ballantyne, MD, discusses non-statin therapies, both approved and in development, for managing dyslipidemias from the floor of the 2024 Family Heart Global Summit.
Elliott Elias, MD, MPH: Overcoming Challenges in Prosthetic Valve Evaluation
Elias discusses the challenges of prosthetic valve evaluation, highlighting the role of sonographers, Doppler imaging, and the importance of ongoing training.
The Value of Team-Based Care, Technology in Managing CVD Risk Factors, with Benjamin Scirica, MD
Benjamin Scirica, MD, discusses the importance of team-based care and leveraging technology to optimize the management of cardiovascular risk factors.
Nihar Desai, MD: PROMPT-Lipid and EHR-Based Interventions for Improving Care
Nihar Desai, MD, discusses the results of the PROMPT-Lipid trial while on-site at the 2024 Family Heart Global Summit.
Laurence Sperling, MD: Population Health Approaches to Cardiovascular Disease Prevention
Laurence Sperling, MD, discusses his presentation from the 2024 Family Heart Global Summit examining public health efforts for prevention of cardiovascular disease.
The Role of Virology in Rheumatic Disease, with Leonard Calabrese, DO
Calabrese discussed the multi-faceted role of viral infections in the field of rheumatology ahead of the 2024 CCR West meeting.
Acne and Rosacea Updates 2024, with James Del Rosso, DO
Del Rosso reviews several key highlights from his Maui Derm presentation on acne and rosacea updates from 2024.
Updates on Benzoyl Peroxide Use for Acne, with James Del Rosso, DO
Del Rosso highlights points from his conference talk on benzoyl peroxide (BPO) use among patients with acne and other updates.
Tom C. Nguyen, MD: Evolving Roles of TAVR, SAVR in Aortic Valve Disease
As advancements in valvular technology progress, Nguyen highlights the need for long-term data and multidisciplinary collaboration to improve patient outcomes.
Atypical Clinical Presentations of Blistering Disease, with Donna Culton, MD, PhD
This segment of her interview featured a conversation about the biggest takeaways and notable case series presented in Culton’s talk at Maui Derm NP+PA Fall.
Updates on the Diagnosis of Blistering Diseases, with Donna Culton, MD, PhD
This interview with Culton featured a discussion of key challenges faced when treating patients with blistering diseases such as pemphigus and bullous pemphigoid.
